Public Health

What Is the Price of a Broken Hip in India?
Tech & Innovation What Is the Price of a Broken Hip in India?

Today we're joined by James Maitland, a leading expert on the complex intersection of healthcare law, corporate accountability, and the pharmaceutical industry. He has spent decades analyzing how multinational corporations navigate legal systems and the profound impact their actions have on

Stanford Study Reveals Secret to Scar-Free Facial Healing
Clinical & Pharma Stanford Study Reveals Secret to Scar-Free Facial Healing

The common observation that a cut on the cheek often vanishes while a similar injury on an arm leaves a permanent mark has long been a medical curiosity, but a groundbreaking study from Stanford Medicine has now unraveled the precise biological reasons for this phenomenon. By investigating the

Is This the Future of Connecticut Pediatric Care?
Clinical & Pharma Is This the Future of Connecticut Pediatric Care?

A significant shift in the landscape of pediatric medicine is taking shape in Connecticut, marked by a landmark joint announcement from two of the state's most influential health and academic institutions. Connecticut Children’s and the University of Connecticut (UConn) School of Medicine have

Medicaid Pays for Gene Therapy Only if It Works
Clinical & Pharma Medicaid Pays for Gene Therapy Only if It Works

A life once dictated by the unceasing rhythm of pain and the sterile confines of a hospital room has been fundamentally rewritten for Serenity Cole, an 18-year-old from St. Louis whose story embodies both the immense promise and the staggering financial challenge of modern medicine. For years,

What Can Alaska's Pandemic Teach Us About The Next One?
Clinical & Pharma What Can Alaska's Pandemic Teach Us About The Next One?

A newly released and exhaustive report from Alaska's public health officials offers a granular post-mortem of the COVID-19 pandemic, transforming the state's challenging experience into a crucial set of lessons for inevitable future health crises. By methodically dissecting the outbreak from the

A Rare Drug Puts FDA's New Reforms to the Test
Clinical & Pharma A Rare Drug Puts FDA's New Reforms to the Test

The promise of rapidly delivering life-saving treatments to patients is often mired in a complex web of regulation, but a series of ambitious reforms initiated by the Food and Drug Administration in 2025 sought to change that dynamic. Against a backdrop of a turbulent year for its parent agency,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later